NCT06430983
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
- Locations
-
- The Second Affiliated Hospital of Nanjing Medical University Nanjing, Jiangsu, China
Clinical trial condition
Explore clinical trials studying Recurrent Liver Cancer. Study availability and eligibility vary by location and protocol.
NCT06430983